We are live on ! Find out more
MPU

MVM Partners (UK) Portfolio holdings

AUM $149M
1-Year Est. Return 6.81%
This Fund
S&P 500
This Quarter Est. Return
+12.29%
1 Year Est. Return
+6.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$149M
AUM Growth
-$134M
Cap. Flow
-$167M
Cap. Flow %
-111.52%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
FNA
Paragon 28, Inc.
FNA
+$113M
2
OPTN
OptiNose
OPTN
+$45.5M
3
MDXH icon
MDxHealth
MDXH
+$7.56M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNA
1
DELISTED
Paragon 28, Inc.
FNA
$149M 100%
8,385,972
-6,158,018
-42% -$113M
MDXH icon
2
MDxHealth
MDXH
$22.4M
-916,666
Closed -$7.56M
OPTN
3
DELISTED
OptiNose
OPTN
-833,333
Closed -$45.5M

Similar funds

MVM Partners (UK)'s Q3 2022 Portfolio in Review

As of Q3 2022, MVM Partners (UK) held 3 positions worth $149M, down 47% from $283M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MVM Partners (UK) withdrew a net $167M in Q3 2022, closing 2 positions and reducing 1 holding. Its most notable exit was OptiNose, an estimated $45.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MVM Partners (UK)'s biggest Q3 2022 reduction was Paragon 28, Inc., cutting an estimated $113M.
  • MVM Partners (UK) fully exited OptiNose in Q3 2022, selling an estimated $45.5M.
  • MVM Partners (UK)'s ten largest holdings make up 100% of its $149M portfolio in Q3 2022.
  • MVM Partners (UK) opened 0 new positions and closed 2 in Q3 2022.
  • MVM Partners (UK)'s portfolio value fell 47% quarter-over-quarter to $149M.

Based on MVM Partners (UK)'s 13F filing for Q3 2022, filed 25 Oct 2024.